A phase II study in 46 patients reported good tolerability over 28 days with a small reduction in psychosis versus placebo using SAPS.
Should read:
A phase II study in 59 patients reported good tolerability over 28 days with a small reduction in psychosis versus placebo using SAPS.
Last sentence, which previously read:
Eleven percent of patients in the treatment group withdrew from the trial because of worsening psychotic symptoms.
Six patients in the treatment group withdrew from the trial because of worsening psychotic symptoms.
The online version of the original article can be found under doi:10.1007/s40265-016-0600-5.
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